I don't think we will be trying to find money... The company has been very clear on the cost benefit of going after FDA approval, and the reasons behind it. If we were going to just throw something on the shelf, with all the others we could have done that a long time ago..
Plus why would we go after the top of the cream only to undercut ourselves with a cheaper OTC option? One of the key parts of FDA approval is protection from OTC products/claims for a timeframe.
Bot Chart, page-1076
-
- There are more pages in this discussion • 12,674 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |